NDC 69443-019

NDC 69443-019

NDC 69443-019 is a Injection, Suspension, Liposomal in the Drug For Further Processing category. It is labeled and distributed by Baxter Oncology Gmbh.

Product ID69443-019_ae58d7e5-545f-4662-b02f-3f3b7181270a
NDC69443-019
Product TypeDrug For Further Processing
Proprietary NameNDC 69443-019
Dosage FormInjection, Suspension, Liposomal
Marketing Start Date2020-08-05
Marketing Category/ DRUG FOR FURTHER PROCESSING
Labeler NameBaxter Oncology GmbH

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.